ENVESTNET ASSET MANAGEMENT INC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 160 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$219,639
-66.0%
19,149
-24.9%
0.00%
Q2 2023$645,456
+3.4%
25,502
+31.6%
0.00%
Q1 2023$624,004
+17.3%
19,373
-32.8%
0.00%
Q4 2022$531,999
+37.8%
28,819
+101.4%
0.00%
Q3 2022$386,000
+162.6%
14,310
+34.1%
0.00%
Q2 2022$147,000
-40.0%
10,668
-14.9%
0.00%
Q1 2022$245,000
-26.0%
12,543
-38.2%
0.00%
Q4 2021$331,000
-66.5%
20,294
-42.8%
0.00%
-100.0%
Q3 2021$989,000
-4.4%
35,491
+1.6%
0.00%0.0%
Q2 2021$1,035,000
+206.2%
34,933
+189.2%
0.00%
Q1 2021$338,000
+24.3%
12,080
+26.1%
0.00%
Q4 2020$272,0000.0%9,583
-11.4%
0.00%
Q3 2020$272,000
+6.7%
10,813
+3.4%
0.00%
Q2 2020$255,000
+59.4%
10,456
-3.4%
0.00%
Q1 2020$160,000
-19.6%
10,828
-11.7%
0.00%
Q4 2019$199,000
+19800.0%
12,262
+45314.8%
0.00%
Q2 2017$1,0000.0%270.0%0.00%
Q1 2017$1,0000.0%270.0%0.00%
Q4 2016$1,000270.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$48,000,00065.50%
Essex Woodlands Management, Inc. 3,842,047$118,335,00025.90%
Rhenman & Partners Asset Management AB 203,181$6,258,0000.77%
EAM Global Investors LLC 44,898$1,383,0000.72%
Fosun International Ltd 319,313$9,835,0000.62%
EAM Investors, LLC 113,096$3,483,0000.58%
ArrowMark Colorado Holdings LLC 1,735,699$53,460,0000.53%
Perceptive Advisors 618,957$19,064,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 111,360$3,430,0000.45%
Schonfeld Strategic Advisors LLC 83,700$2,578,0000.19%
View complete list of REVANCE THERAPEUTICS INC shareholders